Search results
The NxStage System One with PureFlow SL is a preconfigured FDA-cleared hemodialysis system, designed, tested, and validated to yield AAMI/ANSI/ ISO quality (which includes standards for chemical and chlorine/chloramine testing) water and dialysate for in-center and home use.*. PureFlow minimizes the delivery, storage, inventory management, and ...
NxStage System One Set Up and Use. This podcast provides a high level overview of the NxStage System One. It is not intended to be used as a training tool or to replace the NxStage System One User’s Guide or the Cartridge Instructions for Use. Return to Training & Resources. Refer to NxSTEPS for NxStage's home hemodialysis training program.
NxStage hemodialysis cyclers support individualized and flexible therapies for . home hemodialysis, including more frequent, solo, nocturnal, and other custom therapies prescribed based on patient needs . The systems have been used to perform millions of treatments on thousands of patients, providing life-changing
Hemodialysis machine System One™ NxStage The NxStage System One was designed to simplify the delivery of renal care in acute settings. It gives clinicians the flexibility to deliver the more intensive renal therapies they believe will help their patients, while reducing the strain on overburdened critical care staff and resources.
Training Videos. Watch these training videos to better understand how to use NxStage products both effectively and efficiently. We hope that these videos will help nurses and caretakers, whether in acute facilities, in-center facilities or at home, develop a mastery of our products to ensure safe and successful usage.
Call NxStage customer service at 1-866-697-8243 and confirm the following: Your travel prescription was entered correctly. Your shipping address was entered correctly. The correct supplies and quantities were ordered. Confirm your delivery date.
Hemodialysis machine System One™ NxStage The NxStage System One was designed to simplify the delivery of renal care in acute settings. It gives clinicians the flexibility to deliver the more intensive renal therapies they believe will help their patients, while reducing the strain on overburdened critical care staff and resources.
